Shire and Supernus Pharmaceuticals filed suit against Sandoz over three patents related to the use of guanfacine in the treatment of behavioral disorders. 1/6, District of Colorado, 1:2012cv00040.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.
